BPC-157 Chemical Structure: Sequence, Formula & Molecular Properties

Direct Structural Overview of BPC-157

The bpc 157 chemical structure is a synthetic pentadecapeptide defined by the primary sequence L-Glycyl-L-glutamyl-L-prolyl-L-prolyl-L-prolyl-L-glycyl-L-lysyl-L-prolyl-L-alanyl-L-aspartyl-L-aspartyl-L-alanyl-L-glycyl-L-leucyl-L-valine (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val). It possesses a molecular formula of C62H98N16O22 and a total molecular mass of approximately 1419.53 g/mol.

Derived structurally from a fragment of naturally occurring human gastric juice protein known as Body Protection Compound (BPC), this sequence exhibits high structural stability. Unlike many linear signaling peptides that undergo rapid enzymatic degradation in solution, the specific spatial arrangement of amino acids within BPC-157 confers resistance to proteolysis, rendering it a uniquely stable focal point for in vitro and preclinical tissue regeneration assays.

Primary Amino Acid Sequence and Derivation

The primary sequence of BPC-157 represents a specific target fragment within the larger native BPC protein complex found naturally in mammalian gastric secretions. By isolating this specific 15-residue sequence, researchers established that the bioactivity of the parent protein could be preserved in a significantly smaller molecule. The full sequence reads from the N-terminus to the C-terminus as follows: H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH.

A critical feature of this peptide chain is the alternating cluster of hydrophobic and hydrophilic residues. The inclusion of charged acidic residues (glutamic acid at position 2, aspartic acid at positions 10 and 11) alongside basic residues (lysine at position 7) creates distinct electrostatic regions along the peptide backbones. These ionic characteristics dictate how the molecule folds in aqueous environments and how it interacts with cellular membranes and cell-surface receptors in laboratory assays.

Conformational Stability and the Proline-Rich Core

A defining characteristic of the bpc 157 chemical structure is its high proportion of proline residues. Containing four proline units (positions 3, 4, 5, and 8), the sequence features a rigid proline-rich core. Proline possesses a cyclic side chain bound to the peptide backbone nitrogen, restricting torsional rotation around the N-Cα bond and imparting severe steric constraints on the peptide topology.

This structural rigidity prevents the peptide from collapsing into random coil configurations that are easily targeted by standard endopeptidases and exopeptidases. Preclinical stability studies indicate that this proline architecture allows BPC-157 to remain intact across a wide pH range, including acidic conditions simulating gastric juice (pH 1.0–2.0), as well as neutral buffer solutions. Laboratory investigators studying research peptides frequently leverage this structural robustness to perform extended benchtop assays without rapid peptide breakdown.

Physicochemical Parameters: Molecular Weight, Isoelectric Point, and Solubility

To properly handle and characterize BPC-157 in analytical settings, researchers must reference its baseline physicochemical properties. The net chemical data for the peptide is summarized below:

Molecular Formula: C62H98N16O22 | Monoisotopic Mass: ~1418.69 Da | Average Molecular Weight: 1419.53 g/mol | Calculated Isoelectric Point (pI): ~4.03 | Net Charge at pH 7.0: Negative (-2).

Due to the presence of multiple carboxylic acid functional groups (glutamic acid and aspartic acid residues), BPC-157 exhibits an overall acidic character. It is freely soluble in polar solvents, such as sterile deionized water, phosphate-buffered saline (PBS), and dilute acetic acid. High solubility in aqueous media facilitates precise preparation for high-performance liquid chromatography (HPLC) calibration curves and mass spectrometry profiling.

Preclinical Mechanisms: Angiogenesis and Cellular Migration Pathways

In vitro and animal model research indicates that the distinct structural conformation of BPC-157 enables binding interactions that trigger cascades essential to cell survival and tissue remodeling. Preclinical studies suggest that BPC-157 modulates the vascular endothelial growth factor (VEGF) pathway, upregulating VEGFR2 expression and promoting capillary tube formation (angiogenesis) in endothelial cell culture models.

Additionally, structural analysis links BPC-157 to the activation of the focal adhesion kinase (FAK) and paxillin pathway. This signal transduction cascade is vital for promoting cellular migration and cytoskeletal rearrangement. In vitro assays demonstrate that cells exposed to BPC-157 exhibit accelerated migration speed across simulated wound gaps, highlighting the compound's functional role in accelerating cell mobility and extracellular matrix assembly.

Targeted Research Applications: Tendon, Ligament, Muscle, and Gut Line Repair

Because of its specific primary structure and resulting downstream signaling, BPC-157 is widely studied in preclinical models of dense connective tissue and mucosal repair. Role studies demonstrate that the peptide serves as a tissue repair research compound, studied primarily for accelerated repair of tendon, ligament, muscle, and gut lining via localized angiogenesis and cellular migration to injury sites.

In rodent models of transected Achilles tendons and collateral ligament tears, administration of BPC-157 correlates with increased collagen type I synthesis, higher fibroblast density, and improved mechanical tensile strength compared to control groups. Similarly, in vitro gut epithelial assays demonstrate that the peptide reinforces tight junction integrity (including claudin and occludin expression), protecting gut mucosa from chemical and ischemic stressors. Researchers interested in exploring these pathways can review the verified BPC-157 product specifications in our catalog.

Comparative Structure Analysis: BPC-157, TB-500, GHK-Cu, and KPV

When designing tissue repair experiments, researchers often evaluate BPC-157 alongside other regenerative signaling molecules. While BPC-157 operates as a 15-amino acid proline-rich pentadecapeptide focused on VEGFR2 activation and FAK-paxillin signaling, TB-500 represents a synthetic 43-amino acid peptide fragment (specifically matching the active site of Thymosin Beta-4) that regulates actin monomer sequestering to facilitate cell motility.

In contrast, GHK-Cu is a small tripeptide complex (Gly-His-Lys) bound to copper(II), operating primarily through gene transcription alteration and remodeling of extracellular matrix metalloproteinases. Meanwhile, peptides like KPV utilize a tripeptide structure (Lys-Pro-Val) derived from alpha-MSH to target inflammatory nuclear factor kappa B (NF-κB) pathways. Each of these compounds features distinct amino acid architecture, molecular weights, and primary binding targets, making them complementary subjects in multi-variable cellular regeneration protocols.

Analytical Purity Verification: HPLC, Mass Spectrometry, and COA Compliance

Evaluating the accuracy of the bpc 157 chemical structure requires strict analytical validation. Impurities generated during solid-phase peptide synthesis (SPPS)—such as truncated sequences, deletion sequences, or racemized side products—can distort experimental outcomes and alter molecular binding dynamics.

At PX1 Research, every production lot undergoes rigorous testing in an ISO 17025 accredited laboratory. Quality verification requires two primary analytical methodologies:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Measures chemical purity by separating the target BPC-157 peak from closely related synthesis bypass products. PX1 guarantees a purity threshold of ≥98.0%.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass match (1419.5 Da ± 1 Da), verifying that the amino acid sequence corresponds precisely to the target chemical formula without molecular alterations.

Every vial is fully traceable with a batch-specific Certificate of Analysis (COA) detailing HPLC chromatograms and mass spectral data. Researchers can inspect these standards across our full catalog of all research peptides.

Endotoxin Testing and Quality Standards for In Vitro Assay Rigor

Bacterial endotoxins (lipopolysaccharides) represent a major confounding variable in preclinical cell culture and tissue model assays. High endotoxin contamination induces non-specific inflammatory signaling via Toll-like receptor 4 (TLR4), masking the genuine biological activity of the bpc 157 chemical structure.

PX1 Research enforces strict endotoxin limits (<0.1 EU/mg) verified via Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing. All products are manufactured in GMP-compliant facilities located within the USA, ensuring that reagents meet strict chemical specifications prior to distribution. For large-scale laboratory requirements or institutional orders, details regarding volume procurement can be reviewed on our wholesale accounts portal.

Reconstitution Protocol and Laboratory Handling Standards

To preserve the structural integrity of BPC-157, researchers must adhere to standardized laboratory reconstitution procedures. Lyophilized BPC-157 powder should be stored at -20°C prior to reconstitution to maintain long-term peptide stability.

Reconstitution guidelines for analytical research include:

1. Allow the sealed vial to adjust to room temperature before opening to avoid moisture condensation inside the glass matrix.

2. Reconstitute using sterile Bacteriostatic Water or sterile 0.9% Sodium Chloride injection grade solution.

3. Direct the solvent stream gently along the glass inner wall rather than directly onto the lyophilized cake.

4. Swirl the vial gently until the solid is completely dissolved. Avoid vigorous vortexing or agitation, which can induce physical shear forces and degrade peptide secondary structures.

Once reconstituted, aqueous BPC-157 solutions should be stored at 2°C to 8°C and utilized within short-term experimental windows, or aliquoted and stored at -80°C to prevent freeze-thaw degradation cycles. Additional handling technical guides are accessible through the PX1 Research Hub.